American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Raymond James & Associates Buys Shares of 10,044 The Beauty Health Company (NASDAQ:SKIN)

Raymond James & Associates Buys Shares of 10,044 The Beauty Health Company (NASDAQ:SKIN)

Raymond James & Associates bought a new position in shares of The Beauty Health Company (NASDAQ:SKIN – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities &... More of this article »
Image about Raymond James & Associates Has $78,000 Stake in Acelyrin, Inc. (NASDAQ:SLRN)

Raymond James & Associates Has $78,000 Stake in Acelyrin, Inc. (NASDAQ:SLRN)

Raymond James & Associates reduced its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 43.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The... More of this article »
Image about Raymond James & Associates Trims Holdings in Omeros Co. (NASDAQ:OMER)

Raymond James & Associates Trims Holdings in Omeros Co. (NASDAQ:OMER)

Raymond James & Associates reduced its stake in Omeros Co. (NASDAQ:OMER – Free Report) by 75.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 10,925 shares of the... More of this article »
Image about Desktop Metal, Inc. (NYSE:DM) Shares Sold by Raymond James & Associates

Desktop Metal, Inc. (NYSE:DM) Shares Sold by Raymond James & Associates

Raymond James & Associates lessened its stake in shares of Desktop Metal, Inc. (NYSE:DM – Free Report) by 39.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The... More of this article »
Image about Raymond James & Associates Purchases Shares of 14,462 Rackspace Technology, Inc. (NASDAQ:RXT)

Raymond James & Associates Purchases Shares of 14,462 Rackspace Technology, Inc. (NASDAQ:RXT)

Raymond James & Associates acquired a new position in Rackspace Technology, Inc. (NASDAQ:RXT – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The... More of this article »
Image about BNY Mellon Municipal Income, Inc. (NYSE:DMF) Shares Sold by Raymond James & Associates

BNY Mellon Municipal Income, Inc. (NYSE:DMF) Shares Sold by Raymond James & Associates

Raymond James & Associates reduced its holdings in BNY Mellon Municipal Income, Inc. (NYSE:DMF – Free Report) by 20.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities... More of this article »
Image about Gain Therapeutics, Inc. (NASDAQ:GANX) Shares Sold by Raymond James & Associates

Gain Therapeutics, Inc. (NASDAQ:GANX) Shares Sold by Raymond James & Associates

Raymond James & Associates reduced its stake in shares of Gain Therapeutics, Inc. (NASDAQ:GANX – Free Report) by 29.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 23,788 shares... More of this article »
Image about Raymond James & Associates Buys 9,696 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Raymond James & Associates Buys 9,696 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA)

Raymond James & Associates grew its position in Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) by 48.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 29,917 shares of the... More of this article »
Image about Mattel (MAT) – Analysts’ Recent Ratings Changes

Mattel (MAT) – Analysts’ Recent Ratings Changes

Mattel (NASDAQ: MAT) has recently received a number of price target changes and ratings updates: 4/24/2024 – Mattel had its “neutral” rating reaffirmed by analysts at Roth Mkm. They now have a $21.00 price target... More of this article »
Image about Estée Lauder Companies (EL) – Analysts’ Recent Ratings Updates

Estée Lauder Companies (EL) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Estée Lauder Companies (NYSE: EL): 5/2/2024 – Estée Lauder Companies had its price target lowered by analysts at JPMorgan Chase & Co. from $169.00... More of this article »
Image about Weekly Analysts’ Ratings Changes for Leidos (LDOS)

Weekly Analysts’ Ratings Changes for Leidos (LDOS)

A number of firms have modified their ratings and price targets on shares of Leidos (NYSE: LDOS) recently: 5/1/2024 – Leidos had its price target raised by analysts at Royal Bank of Canada from $120.00 to $140.00. They now have... More of this article »
Image about Analysts’ Recent Ratings Updates for ResMed (RMD)

Analysts’ Recent Ratings Updates for ResMed (RMD)

ResMed (NYSE: RMD) recently received a number of ratings updates from brokerages and research firms: 4/26/2024 – ResMed had its price target raised by analysts at Royal Bank of Canada from $187.00 to $200.00. They now have a... More of this article »
Image about Grafton Group (LON:GFTU) Stock Rating Reaffirmed by Royal Bank of Canada

Grafton Group (LON:GFTU) Stock Rating Reaffirmed by Royal Bank of Canada

Grafton Group (LON:GFTU – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at Royal Bank of Canada in a research report issued to clients and investors on Friday,... More of this article »
Image about Taylor Wimpey (LON:TW) Receives Overweight Rating from JPMorgan Chase & Co.

Taylor Wimpey (LON:TW) Receives Overweight Rating from JPMorgan Chase & Co.

Taylor Wimpey (LON:TW – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts at JPMorgan Chase & Co. in a report released on Friday, Digital Look reports. A number of other... More of this article »
Image about Barratt Developments’ (BDEV) “Overweight” Rating Reiterated at JPMorgan Chase & Co.

Barratt Developments’ (BDEV) “Overweight” Rating Reiterated at JPMorgan Chase & Co.

Barratt Developments (LON:BDEV – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at JPMorgan Chase & Co. in a research note issued on Friday, Digital Look reports. Several... More of this article »